Live feed
Filing
SC 13D
SC 13D0000914760-15-000279·Akari Therapeutics Plc
Schedule 13D ownership disclosure
Akari Therapeutics Plc
Security class unavailable · CUSIP: 00972G108
Event date: 2015-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 722,345,600
- Percent of class
- 61.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914760-15-000279
- Form type
- SC 13D
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Sep 29, 2015
- Reporting period
- Sep 18, 2015
- Description
- Schedule 13D beneficial ownership